RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makinanayi Ticaret AS (IST:RTALB) YoY EBITDA Growth : -53.70% (As of Sep. 2023)

View and export this data going back to 2014. Start your Free Trial

What is RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makinanayi Ticaret AS YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makinanayi Ticaret AS's YoY EBITDA Growth for the quarter that ended in Sep. 2023 was -53.70%.

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makinanayi Ticaret AS's EBITDA per Share for the three months ended in Sep. 2023 was ₺0.60.

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makinanayi Ticaret AS YoY EBITDA Growth Historical Data

The historical data trend for RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makinanayi Ticaret AS's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makinanayi Ticaret AS YoY EBITDA Growth Chart

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makinanayi Ticaret AS Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

YoY EBITDA Growth

Get a 7-Day Free Trial

-65.09

148.65

1,064.13

272.46

-18.93

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makinanayi Ticaret AS Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
YoY EBITDA Growth	Get a 7-Day Free Trial															160.12	141.29	-57.37	114.23	-53.70

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makinanayi Ticaret AS YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makinanayi Ticaret AS's YoY EBITDA Growth for the fiscal year that ended in Dec. 2022 is calculated as:

	YoY EBITDA Growth (A: Dec. 2022 )
=	(EBITDA per Share (A: Dec. 2022 )	-	EBITDA per Share (A: Dec. 2021 ))	/	\| EBITDA per Share (A: Dec. 2021 ) \|
=	(3.234	-	3.989)	/	\| 3.989 \|
=	-18.93 %

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makinanayi Ticaret AS's YoY EBITDA Growth for the quarter that ended in Sep. 2023 is calculated as:

	YoY EBITDA Growth (Q: Sep. 2023 )
=	(EBITDA per Share (Q: Sep. 2023 )	-	EBITDA per Share (Q: Sep. 2022 ))	/	\| EBITDA per Share (Q: Sep. 2022 )) \|
=	(0.601	-	1.298)	/	\| 1.298 \|
=	-53.70 %

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makinanayi Ticaret AS YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makinanayi Ticaret AS's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makinanayi Ticaret AS (IST:RTALB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makina Sanayi Ticaret AS (IST:RTALB) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

Plastikciler Organize Sanayi Bolgesi (GEPOSB), Cumhuriyet Cad. No:3, Kocaeli, Gebze, TUR, 41400

Website

http://www.rtalabs.com.tr

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makina Sanayi Ticaret AS is engaged in research, development, and production of Vitro diagnostics. The company offers Real-Time PCR Kits, Nucleic Acid Isolation Kits, and DNA qPCR Probe Master Mix Kit.

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makinanayi Ticaret AS (IST:RTALB) Headlines

No Headlines